{"id":"https://openalex.org/W2500965784","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.3596","title":"Denosumab in patients with bone metastases from prostate, breast, and other cancers and elevated urinary N-telopeptide (uNTx) during intravenous bisphosphonate (IV BP) therapy: Final results of a randomized, phase II study","display_name":"Denosumab in patients with bone metastases from prostate, breast, and other cancers and elevated urinary N-telopeptide (uNTx) during intravenous bisphosphonate (IV BP) therapy: Final results of a randomized, phase II study","publication_year":2008,"publication_date":"2008-05-20","ids":{"openalex":"https://openalex.org/W2500965784","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.3596","mag":"2500965784"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.26.15_suppl.3596","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.3596","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.3596","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007779528","display_name":"Karim S. Fizazi","orcid":"https://orcid.org/0000-0002-6068-9474","observed_orcids":["https://orcid.org/0000-0002-6068-9474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Fizazi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112146037","display_name":"Allan Lipton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Lipton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107872282","display_name":"Xavier Mariette","orcid":"https://orcid.org/0000-0002-4244-5417","observed_orcids":["https://orcid.org/0000-0002-4244-5417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"X. Mariette","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110390886","display_name":"T. Suarez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Suarez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110057393","display_name":"J.J. Body","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Body","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088964837","display_name":"Yasmin H. Rahim","orcid":"https://orcid.org/0000-0001-8746-3240","observed_orcids":["https://orcid.org/0000-0001-8746-3240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Rahim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025364402","display_name":"Julie R. Gralow","orcid":"https://orcid.org/0000-0003-3837-9928","observed_orcids":["https://orcid.org/0000-0003-3837-9928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. R. Gralow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"G. Gao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Gao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001951835","display_name":"Leang\u2010Shin Wu","orcid":"https://orcid.org/0000-0002-9384-2527","observed_orcids":["https://orcid.org/0000-0002-9384-2527"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"S. Jun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Jun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"15_suppl","first_page":"3596","last_page":"3596"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11219","display_name":"Bone Metabolism and Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/denosumab","display_name":"denosumab","score":0.8889999985694885},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.8489999771118164},{"id":"https://openalex.org/keywords/rankl-inhibition","display_name":"RANKL inhibition","score":0.7409999966621399},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.7540000081062317},{"id":"https://openalex.org/keywords/urinary-n-telopeptide","display_name":"urinary N-telopeptide","score":0.8339999914169312},{"id":"https://openalex.org/keywords/bone-resorption","display_name":"bone resorption","score":0.9509999752044678},{"id":"https://openalex.org/keywords/skeletal-related-events","display_name":"skeletal-related events","score":0.8870000243186951},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9169999957084656},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":1.0},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/zoledronic-acid","display_name":"zoledronic acid","score":0.7590000033378601},{"id":"https://openalex.org/keywords/hypophosphatemia","display_name":"hypophosphatemia","score":0.7979999780654907},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.6169999837875366},{"id":"https://openalex.org/keywords/osteoclasts","display_name":"osteoclasts","score":0.6259999871253967},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.6269999742507935},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.42399999499320984},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4650000035762787},{"id":"https://openalex.org/keywords/bone-pain","display_name":"bone pain","score":0.39800000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9399486184120178},{"id":"https://openalex.org/C2776286101","wikidata":"https://www.wikidata.org/wiki/Q408283","display_name":"Denosumab","level":3,"score":0.7977835536003113},{"id":"https://openalex.org/C2776326535","wikidata":"https://www.wikidata.org/wiki/Q218507","display_name":"Zoledronic acid","level":2,"score":0.5782646536827087},{"id":"https://openalex.org/C673006","wikidata":"https://www.wikidata.org/wiki/Q4941581","display_name":"Bone resorption","level":2,"score":0.5625215172767639},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5607551336288452},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.49389487504959106},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4497584402561188},{"id":"https://openalex.org/C170033053","wikidata":"https://www.wikidata.org/wiki/Q952019","display_name":"Bone remodeling","level":2,"score":0.41736355423927307},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3980323076248169},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3708001673221588},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.34182387590408325},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2868531346321106}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2008.26.15_suppl.3596","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.3596","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.3596","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2103904089","https://openalex.org/W2530836433","https://openalex.org/W2325981662","https://openalex.org/W4247361750","https://openalex.org/W2141272738","https://openalex.org/W7098435529","https://openalex.org/W2264488606","https://openalex.org/W2088982930","https://openalex.org/W2157193896","https://openalex.org/W2141378241"],"abstract_inverted_index":{"3596":[0],"Background:":[1],"Patients":[2,344,413],"(pts)":[3],"with":[4,57,127,184,192,222,272,345],"elevated":[5,273],"levels":[6],"of":[7,66,106,125,182,250,293,299,309,398],"uNTx,":[8],"representing":[9,213],"excessive":[10],"bone":[11,32,58,240],"resorption,":[12],"are":[13],"at":[14,137,210,352,401],"high":[15],"risk":[16],"for":[17,434],"skeletal-":[18],"related":[19,253],"events":[20,233,416],"(SREs),":[21],"disease":[22],"progression,":[23],"and":[24,84,87,170,245],"death":[25,260],"(Coleman,":[26],"J":[27],"Clin":[28],"Oncol":[29],"2005).":[30],"Osteoclast-mediated":[31],"resorption":[33],"is":[34],"regulated":[35],"by":[36,42,81],"RANKL,":[37],"which":[38],"can":[39],"be":[40],"inhibited":[41],"denosumab,":[43,255],"a":[44,103],"fully":[45],"human":[46],"monoclonal":[47],"antibody":[48],"against":[49],"RANKL.":[50],"Methods:":[51],"Eligible":[52],"pts":[53,126,183,271,301],"(n":[54,111,116,163,167,172,322,329,336,341],"=":[55,99,112,117,164,168,173,323,330,337,342],"111":[56],"metastases":[59],"or":[60,101,114,445,448],"myeloma;":[61],"on":[62,150],"\u2265":[63],"8":[64],"weeks":[65,96],"IV":[67,91,152,195,226,277,288,319],"BP":[68,92,153,227,278],"before":[69],"randomization;":[70],"screening":[71],"uNTx":[72,86,128,185,274,282,346,371,400],">":[73],"50":[74,130,187,348,375],"nM":[75,131,349,376,403],"BCE/mM":[76,132,350,377,404],"creatinine":[77],"[Cr])":[78],"were":[79,208,267],"stratified":[80],"tumor":[82],"type":[83],"baseline":[85],"randomized":[88],"to":[89,254,265,297,370,373],"continue":[90],"therapy":[93],"every":[94],"4":[95],"(Q4W;":[97],"n":[98],"37)":[100],"receive":[102],"subcutaneous":[104],"injection":[105],"denosumab":[107,193,237,266,280,294,310,436],"180":[108,326,333],"mg":[109,327,334],"Q12W":[110,328],"36)":[113,338],"Q4W":[115,335],"38).":[118],"The":[119,141,147,229,290],"primary":[120],"endpoint":[121],"was":[122,144,156,188,220,256,295,431],"the":[123,178,214,236,435,439],"proportion":[124],"<":[129,135,186,203,347,374],"Cr":[133,351,378,405],"(uNTx":[134],"50)":[136],"week":[138,176,211,353],"13.":[139],"Results:":[140],"median":[142,148,380,429],"age":[143],"62":[145],"years.":[146],"time":[149,368],"prior":[151],"(mostly":[154],"zoledronate)":[155],"5.3":[157],"months.":[158],"Primary":[159],"tumors":[160],"included":[161,239],"prostate":[162],"50),":[165],"breast":[166],"46),":[169],"other/myeloma":[171],"15).":[174],"At":[175],"13,":[177],"%":[179,356],"(95%":[180,357],"CI)":[181,358],"greater":[189],"after":[190],"treatment":[191,216,440],"vs":[194,199],"BP:":[196],"71%":[197],"(59%-81%)":[198],"29%":[200],"(15%-46%;":[201],"p":[202],".001),":[204],"respectively.":[205],"Efficacy":[206,317],"data":[207,305],"confirmed":[209],"25,":[212],"entire":[215],"period":[217],"(table).":[218,228],"Denosumab":[219,325,332,340],"associated":[221],"fewer":[223],"SREs":[224],"than":[225,286],"most":[230],"common":[231],"adverse":[232],"(AEs)":[234],"in":[235,311,315],"arms":[238,437],"pain,":[241],"nausea,":[242],"anemia,":[243],"constipation,":[244],"asthenia.":[246],"One":[247],"serious":[248],"AE":[249,291],"hypophosphatemia,":[251],"possibly":[252],"reported;":[257],"no":[258],"treatment-related":[259],"occurred.":[261],"No":[262],"neutralizing":[263],"antibodies":[264],"observed.":[268],"Conclusions:":[269],"Among":[270],"despite":[275],"previous":[276],"therapy,":[279],"normalized":[281],"significantly":[283],"more":[284],"frequently":[285],"ongoing":[287],"BP.":[289],"profile":[292],"similar":[296],"that":[298],"cancer":[300],"receiving":[302],"treatment.":[303],"These":[304],"support":[306],"further":[307],"evaluation":[308],"phase":[312],"III":[313],"trials":[314],"oncology.":[316],"Endpoints":[318],"Bisphospho-":[320],"nate":[321],"35)":[324],"33)":[331],"Pooled":[339],"69)":[343],"25":[354],"-":[355,379,406,417],"37%":[359],"(22%-55%)":[360],"64%":[361,363,365],"(45%-80%)":[362],"(46%-79%)":[364],"(51%-75%)":[366],"Estimated":[367,395],"(days)":[369,397],"reduction":[372],"(Q1,":[381],"Q3)":[382],"65":[383],"(8,":[384,390,393],"141)":[385],"9":[386,392],"(4,":[387],"11)":[388,391,394],"10":[389],"duration":[396,430],"maintaining":[399],"<50":[402],"25th":[407],"percentilea":[408],"24":[409],"80":[410],"284":[411],"160":[412],"experiencing":[414],"skeletal-related":[415],"n/N":[418],"(%)":[419],"7/35":[420],"(20%)":[421],"4/35":[422],"(11%)":[423],"2/38":[424],"(5%)":[425],"6/73":[426],"(8%)":[427],"aThe":[428],"not":[432],"achieved":[433],"during":[438],"period.":[441],"Author":[442],"Disclosure":[443],"Employment":[444],"Leadership":[446],"Consultant":[447],"Advisory":[449],"Role":[450],"Stock":[451],"Ownership":[452],"Honoraria":[453],"Research":[454],"Expert":[455],"Testimony":[456],"Other":[457],"Remuneration":[458],"Amgen":[459,460]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-08-23T00:00:00"}